nTMS for Motor Mapping of Rolandic Lesions

NCT ID: NCT02879682

Last Updated: 2023-06-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

330 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare presurgical motor mapping by navigated transcranial magnetic stimulation for surgery (nTMS) of rolandic lesions to surgery with mapping without implementing these data into neuronavigation as control.

Primary objective: Permanently new postoperative deficit is lower when the preoperative motor mapping is available to the surgeon

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Experimental intervention:

presurgical motor mapping by navigated transcranial magnetic stimulation and fusion with intraoperative neuronavigation

Control intervention:

presurgical motor mapping by navigated transcranial magnetic stimulation without access of the surgeon to this data Follow-up per patient: 6 months Duration of intervention per patient: 45 minutes

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glioma Brain Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

preoperative Mapping
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

nTMS

presurgical motor mapping by nTMS and fusion with intraoperative neuronavigation

Group Type ACTIVE_COMPARATOR

nTMS data available for the surgeon

Intervention Type PROCEDURE

the preoperatively acquired map of the motor cortex by nTMS will be available for the surgeon

non-nTMS

presurgical motor mapping by nTMS without access of the surgeon to these data

Group Type SHAM_COMPARATOR

nTMS data not available for the surgeon

Intervention Type PROCEDURE

the preoperatively acquired map of the motor cortex by nTMS will not be available for the surgeon

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nTMS data available for the surgeon

the preoperatively acquired map of the motor cortex by nTMS will be available for the surgeon

Intervention Type PROCEDURE

nTMS data not available for the surgeon

the preoperatively acquired map of the motor cortex by nTMS will not be available for the surgeon

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* indication for resection of a supratentorial tumor within or adjacent to the primary motor cortex
* preoperative nTMS mapping of the ipsilateral hemisphere
* implementation of the mapping data into preoperative planning
* continuous MEP monitoring - informed consent

Exclusion Criteria

* no motor eloquent tumor
* infratentorial tumor
* no postoperative imaging
* prognosis lower than 3 months of survival - age \<18 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role collaborator

Evangelisches Krankenhaus Bielefeld gGmbH

OTHER

Sponsor Role collaborator

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sandro M Krieg, MD, MBA

Role: PRINCIPAL_INVESTIGATOR

Technical University of Munich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neurosurgery, Klinikum rechts der Isar, TUM

Munich, Bavaria, Germany

Site Status

Charité Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Vivantes Klinikum Neu-Kölln

Berlin, , Germany

Site Status

Klinikum Bielefeld

Bielefeld, , Germany

Site Status

Klinikum Günzburg

Günzburg, , Germany

Site Status

Department of Neurosurgery, University of Messina

Messina, , Italy

Site Status

Universität Bern

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Italy Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5496/12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.